Therefore, further studies on the role of AGR-2 in human prostate cancer and its downstream targets might lead to a better understanding of bone metastasis and may signify AGR-2 as a possible therapeutic target for preventing prostate cancer bone metastasis. Here, AGR2 is linked to prostate cancer.